Request Demo

Last update 07 Jul 2026

Guangdong ProCapZoom Biosciences Co., Ltd.

Subsidiary Company|2019|Guangdong Sheng, China

Last update 07 Jul 2026

Overview

Pipeline

Deal

Translational Medicine

Overview

Basic Info

Introduction

In 2016, Guangdong ProCapZoom Biosciences Co., Ltd. was established in Guangzhou's Huangpu Science City. This high-tech enterprise focuses on the development of precision cell therapies and new drug discovery, dedicated to researching and applying iPS cells in drug development and disease treatment, particularly in tackling malignancies and visual restoration.

Disease Domain	Count

Neoplasms	4
Immune System Diseases	2
Nervous System Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

CAR-NK	3
Small molecule drug	1
Unknown	1
Exosomes	1
Mesenchymal stem cell therapy	1

Top 5 Target	Count

CD19(B-lymphocyte antigen CD19)	1
CD276(CD276 antigen)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 27 Jul 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Phase 1

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

SZ-1003	Advanced Hepatocellular Carcinoma More	Early Phase 1
Allogeneic CD19-CAR-NK Cells(Guangdong ProCapZoom Biosciences) ( CD19 )	Myasthenia Gravis More	Early Phase 1
CD276-targeted CAR-NK(Guangdong ProCapZoom) ( CD276 )	Esophageal Carcinoma More	Preclinical
Allogeneic umbilical cord mesenchymal stem cells (ProCapZoom)	Graft vs Host Disease More	Discovery
CN118791437 Patent Mining	Inflammation More	Discovery

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis